Focus on Rosacea
The Dermatologist is excited to publish this special supplement, Rosacea Treatment Today. An estimated 16 million Americans have rosacea, yet only a small fraction are being treated, according to the National Rosacea Society (NRS).
The impact of the condition extends beyond prominent physical facial symptoms and affects patients psychosocially. Research is also revealing a link to comorbid systemic disorders, such as cardiovascular disease, gastrointestinal disease, neurological and autoimmune diseases, and certain cancers.1
In recent years, great strides have taken place in the understanding of the pathophysiology of rosacea. The special supplement toThe Dermatologist discusses current rosacea treatment in light of the new guidelines and recent research in the field. It covers the latest news (page 7), and highlights notable trends and resources related to rosacea. The Voices Guest Commentary from Richard L. Gallo, MD, PhD, of the NRS, includes information on the new standard classification system, considerations for the treatment of rosacea, and a look toward the future (page 8).
“Beyond the advances in understanding of the pathophysiology of rosacea, clinicians today have at their disposal a growing range of therapeutic options. With the new phenotype-based diagnostic system, it is now possible to address the signs and symptoms of rosacea in a more targeted manner, tailored for each individual patient,” he said.
This special issue provides an overview of the condition and a look at how physicians are implementing the new standard classification system (page 10). In Reconsidering Ocular Rosacea Treatment (page 14), Kara Capriotti, MD, talks about approaching ocular rosacea treatment from a different perspective. In addition, Julie C. Harper, MD, answers top questions about how she approaches rosacea treatment (page 12).
The Rosacea Review section (page 15) highlights the latest published research in rosacea. Continued research in this important area combined with more education about the signs and symptoms of rosacea will lead to improved patient care. In the Rosacea Case (page 17), Dr Barankin examines a case of a patient who presents with erythematous facial papules and pustules.
Lisa B. Samalonis
1. Gallo RL, Granstein RD, Kang S, et al. Rosacea comorbidities and future research: The 2017 update by the National Rosacea Society Expert Committee. J Am Acad Dermatol. 2018;78(1):167-170.